SCHEMBL3883570

SCHEMBL3883570

COC(=O)CCc1ccc(OCc2ccc(C(F)(F)F)cc2)c(-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.42
FFAR1 O14842 1/20 0.42
FFAR2 O15552 1/20 0.42
ENPP2 Q13822 1/20 0.41
CHRNA7 P36544 2/20 0.41
KCNH2 Q12809 1/20 0.41
VCP P55072 1/20 0.40
PPARA Q07869 2/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
ALOX5 P09917 1/20 0.39
PSEN1 P49768 1/20 0.39
PPARD Q03181 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
EPHX2 P34913 1/20 0.38
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3884010 0.92 ENPP2 (0.42) ENPP2RXRARXRBRXRGPTPN1
SCHEMBL3883485 0.90 FFAR4 (0.48) FFAR4FFAR1FFAR2ENPP2VCP
SCHEMBL3883267 0.90 CNR2 (0.44) FFAR4FFAR1ENPP2PTPN1BRD4
SCHEMBL3881998 0.89 ENPP2 (0.53) FFAR4FFAR1ENPP2PTPN1BRD4
SCHEMBL3681761 0.89 ENPP2 (0.44) FFAR4FFAR1ENPP2VCPPTPN1
SCHEMBL3887874 0.88 ENPP2 (0.43) FFAR1ENPP2PTPN1BRD4
SCHEMBL3881133 0.88 ENPP2 (0.53) FFAR4FFAR1ENPP2PTPN1EPHX2
SCHEMBL3881441 0.88 CHRNA7 (0.39) FFAR4FFAR1ENPP2CHRNA7KCNH2
SCHEMBL3886352 0.87 AKT1 (0.42) FFAR4FFAR1FFAR2VCPPPARA
SCHEMBL3883670 0.86 ENPP2 (0.40) FFAR1ENPP2PPARAPTPN1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 FFAR4 115/4885FFAR1 13/4885FFAR2 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.